Skip to main content

JANUS HENDERSON GROUP PLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1274173 LONDON, X0

Position in XENE

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$242,833,352
+$59,786,949 QoQ
Shares Held
4,175,982
+2.3% QoQ
Ownership
4.32%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 96.96279821129498.ToString("F0")% None 3.037201788705028.ToString("F0")%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANUS HENDERSON GROUP PLC holds $15,891,244,813 across 182 Biotechnology names. XENE ranks #14 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XENE

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $242,833,352 4,175,982
2025-12-31 $183,046,403 4,084,034
2025-09-30 $158,346,981 3,943,885
2025-06-30 $111,983,104 3,577,735
2025-03-31 $111,556,869 3,325,093
2024-12-31 $112,376,795 2,866,755
2024-09-30 $100,487,672 2,552,392
2024-06-30 $40,754,569 1,045,257
2024-03-31 $40,534,545 941,569
2023-12-31 $44,496,953 966,065
2023-09-30 $13,059,538 382,305
2023-06-30 $12,602,743 327,344
2023-03-31 $11,505,232 321,465
2022-12-31 $11,505,121 291,786
2022-09-30 $8,441,406 233,834
2022-06-30 $8,416,422 276,674
2022-03-31 $314,290 10,281